However, induction of BIM by MEK or KRASG12C inhibition alone is often insufficient to induce apoptosis in KRAS-mutant cancer cells because BIM is bound and neutralized by pro-survival BCL-2 family proteins such as BCLX-XL or MCL-1. The gene discussed is MCL1; the disease is cancer.